We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
+10.09%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
AUM
$390M
AUM Growth
+$4.4M
Cap. Flow
-$11.6M
Cap. Flow %
-2.97%
Top 10 Hldgs %
36.69%
Holding
189
New
3
Increased
22
Reduced
93
Closed
8

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$8.09M
2
QRVO icon
Qorvo
QRVO
+$3.18M
3
DXCM icon
DexCom
DXCM
+$296K
4
TEAM icon
Atlassian
TEAM
+$225K
5
QLYS icon
Qualys
QLYS
+$221K

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$9.79M
2
CNC icon
Centene
CNC
+$1.4M
3
AAPL icon
Apple
AAPL
+$1.26M
4
AMZN icon
Amazon
AMZN
+$757K
5
LULU icon
lululemon athletica
LULU
+$746K

Sector Composition

Rank Sector Weight
1 Healthcare 24.4%
2 Technology 24.34%
3 Consumer Discretionary 11.23%
4 Communication Services 8.9%
5 Consumer Staples 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUNA
176
DELISTED
Luna Innovations Incorporated
LUNA
$60K 0.02%
10,054
TCRT icon
177
Alaunos Therapeutics
TCRT
$4.79M
$50K 0.01%
131
BDX icon
178
Becton Dickinson
BDX
$48.5B
-1,047
Closed -$279K
CNC icon
179
Centene
CNC
$32.7B
-21,815
Closed -$1.4M
EW icon
180
Edwards Lifesciences
EW
$53.1B
-126,489
Closed -$9.79M
GIS icon
181
General Mills
GIS
$19.8B
-3,293
Closed -$213K
ROKU icon
182
Roku
ROKU
$22.6B
-2,075
Closed -$309K
STBA icon
183
S&T Bancorp
STBA
$1.79B
-12,608
Closed -$289K
UBSI icon
184
United Bankshares
UBSI
$6.59B
-8,451
Closed -$232K
RDS.A
185
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
-6,805
Closed -$218K

Similar funds

Dixon Hubard Feinour & Brown's Q3 2020 Portfolio in Review

As of Q3 2020, Dixon Hubard Feinour & Brown held 189 positions worth $390M, up 1.1% from $385M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Dixon Hubard Feinour & Brown's Q3 2020 filing shows 3 new, 22 increased, 93 reduced and 8 closed positions. Its largest new stake was Qorvo: 25,635 shares worth $3.31M. The largest sale was Edwards Lifesciences, an estimated $9.79M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Dixon Hubard Feinour & Brown's largest Q3 2020 buy was Qorvo: 25,635 shares worth $3.31M.
  • Dixon Hubard Feinour & Brown added most to UnitedHealth in Q3 2020, an estimated $8.09M increase.
  • Dixon Hubard Feinour & Brown's biggest Q3 2020 reduction was Apple, cutting an estimated $1.26M.
  • Dixon Hubard Feinour & Brown fully exited Edwards Lifesciences in Q3 2020, selling an estimated $9.79M.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 37% of its $390M portfolio in Q3 2020.
  • Dixon Hubard Feinour & Brown opened 3 new positions and closed 8 in Q3 2020.
  • Dixon Hubard Feinour & Brown's portfolio value rose 1.1% quarter-over-quarter to $390M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q3 2020, filed 12 Nov 2020.